SLS Earnings Sellas Life Sciences Group, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–30 of 30
| Q2 2026 | 2026-06-30 | -0.10 | 2026-08-11 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.05 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -0.25 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -0.20 | 2025-11-12 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.13 | 2026-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.07 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -0.50 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | -0.42 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.33 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.21 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -1.34 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -1.09 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.77 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.47 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -2.13 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.70 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.39 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.05 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -1.34 | 2023-03-16 | 10-K |
| Q3 2022 | 2021-09-30 | -0.92 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.47 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.16 | 2022-05-12 | 10-Q |
| FY 2021 | 2020-12-31 | -2.11 | 2022-03-31 | 10-K |
| Q3 2021 | 2020-09-30 | -1.83 | 2021-11-12 | 10-Q |
| Q2 2021 | 2020-06-30 | -1.32 | 2021-08-12 | 10-Q |
| Q2 2017 | 2017-06-30 | -0.63 | 2017-08-14 | 10-Q |
| Q2 2017 | 2016-06-30 | -0.30 | 2017-08-14 | 10-Q |
| Q2 2013 | 2013-06-30 | -0.23 | 2013-08-09 | 10-Q |
| Q2 2013 | 2012-06-30 | -0.44 | 2013-08-09 | 10-Q |
| Q2 2012 | 2011-06-30 | -0.26 | 2012-08-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.